Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients https://www.nature.com/articles/s41391-025-01013-3
Discover the world at Altruu, The Discovery Engine
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients https://www.nature.com/articles/s41391-025-01013-3
Addition of a surgery-specific module to a perioperative, telemedicine program for improving functional outcomes after radical prostatectomy: a prospective, multicenter, non-randomized study https://www.nature.com/articles/s41391-025-01026-y
Aging-associated ZNF573 methylation regulates RNF19B-PIK3CA ubiquitination to promote prostate cancer https://www.nature.com/articles/s41388-025-03579-7
Evolving roles for the androgen receptor and its protein interactome in castration-resistant prostate cancer https://www.nature.com/articles/s41388-025-03573-z
Exercise oncology in prostate cancer: from observational insight to prescriptive precision https://www.nature.com/articles/s41416-025-03205-z